Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Veronica Candi
Intravenous (IV) Bortezomib Infusion After Non-Response to Subcutaneous Bortezomib Administration Can Induce Transitory Responses in Multiple Myeloma Patients: Are Some Patients More Sensitive to IV Bortezomib?
British Journal of Haematology
Hematology
Related publications
Home Administration of Bortezomib: Making a Difference to Myeloma Patients' Lives
European Journal of Oncology Nursing
Medicine
Oncology
Bortezomib for the Treatment of Multiple Myeloma Patients
Health Technology Assessment
Medicine
Health Policy
Blood Distribution of Bortezomib and Its Kinetics in Multiple Myeloma Patients
Clinical Biochemistry
Medicine
Clinical Biochemistry
Productivity Costs Related to Bortezomib and Carfilzomib Administration for Multiple Myeloma in Finland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib
Blood Cancer Journal
Oncology
Hematology
Cutaneous Myeloma and Bortezomib
Annals of Hematology
Medicine
Hematology
Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Intracellular Glutathione Determines Bortezomib Cytotoxicity in Multiple Myeloma Cells
Blood Cancer Journal
Oncology
Hematology
Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
